ONTELIAN Trademark

Trademark Overview


On Monday, June 6, 2022, a trademark application was filed for ONTELIAN with the United States Patent and Trademark Office. The USPTO has given the ONTELIAN trademark a serial number of 97444400. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Thursday, November 2, 2023. This trademark is owned by Pfizer Inc.. The ONTELIAN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
ontelian

General Information


Serial Number97444400
Word MarkONTELIAN
Filing DateMonday, June 6, 2022
Status730 - FIRST EXTENSION - GRANTED
Status DateThursday, November 2, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 18, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 15, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192

Trademark Events


Event DateEvent Description
Saturday, November 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 2, 2023SOU EXTENSION 1 GRANTED
Thursday, November 2, 2023SOU EXTENSION 1 FILED
Thursday, November 2, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, June 13, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 6, 2023ASSIGNED TO EXAMINER
Tuesday, April 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 18, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 28, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 28, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, March 16, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 14, 2023ASSIGNED TO EXAMINER
Wednesday, June 15, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 9, 2022NEW APPLICATION ENTERED